Clinical trial PEARL
The PEARL study : Pet imaging as a biomarker of Everolimus Added value in hormone Refractory postmenopausaL women
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | Institut Jules Bordet |
EudraCT Identifier | 2012-004860-22 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02028364 |
Inclusion criteria | ER+/HER2- |
Last update |